Skip to main content
. Author manuscript; available in PMC: 2018 Mar 26.
Published in final edited form as: J Med Virol. 2015 Aug 31;88(2):312–318. doi: 10.1002/jmv.24331

TABLE I.

Characteristics of Study Subjects

Healthy (n = 10) Abd pain, no IBD (n = 10) IBD control (n = 10) IBD on anti-TNFα (n = 10)
Sex
 Male 1 4 6 8
 Female 9 6 4 2
Age (Mean ± SD) 34 ± 8 years 26 ± 13 years 23 ± 8 years 33 ± 13 years
Types of IBD
 CD ------------- 6 4
 UC 4 6
Duration of disease (Average months ± SD) ------------- 23 ± 12 36 ± 12
Severity of disease* ------------- Remission 6 Mild 3 Moderate 1 Remission 6 Mild 1 Moderate 3
Duration of anti-TNFα use ---------------- 28 ± 12 months

CD, Crohn’s Disease; UC, ulcerative colitis.

*

Measured by Physician’s Global Assessment.